The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (17.42) USD. With the latest stock price at 1.00 USD, the upside of Cytosorbents Corp based on DCF is -1842.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.3% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (73.67) - (10.26) | (17.42) |
| Upside | -7467.4% - -1125.8% | -1842.2% |